A Comparative Clinical Investigation of Musician's Preference With Hearing Aids
BF007-2101
1 other identifier
interventional
13
1 country
1
Brief Summary
For this study, Bernafon AG will carry out testing with participants with hearing loss to compare a dedicated music program to a general listening program. The Bernafon hearing aids used for the current study are CEmarked and will be released to the market in early 2022. The goal is to determine whether musicians will perceive a difference and prefer the music program over the default listening program in real-life situations. The devices will also be validated for performance before their release to the market.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2021
CompletedFirst Posted
Study publicly available on registry
June 25, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2021
CompletedJuly 26, 2022
July 1, 2022
1 month
June 8, 2021
July 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The number of patients that prefer the music program for listening to music over the standard listening program as reported in the questionnaire that asks patients to choose a program and state the reason why it was preferred.
A questionnaire will ask patients to choose between the music program and the standard listening program as their preferred program for listening to music. It is not a forced choice as they also have the option to choose "no preference." They are then asked to choose from a checkbox with a list of possible reasons for the preference as well as the ability to write in additional reasons.
10 days
Secondary Outcomes (3)
The number of patients that prefer the sound quality of the music program over the standard listening program measured with a forced choice A/B question on a touch screen.
10 days
The average level of decibels at which patients are able to discriminate the changes in pitch of recorded music samples as measured with a standardized test called the Adaptive Music Perception (AMP) test.
0 days
The average level at which patients correctly repeat sentences presented in background noise using the standardized Gottingen Sentence Test (GOSA).
10 days
Other Outcomes (1)
The number of patients with treatment-related adverse events as assessed by CTCAE v4.0.
0 Days and 10 Days
Study Arms (2)
New Music Program
EXPERIMENTALThe new hearing aid contains the new music program will be worn by all participants at the same time. The participants must switch between the two programs during use to make the comparison.
Standard Listening Program
ACTIVE COMPARATORThe new hearing aid also contains the standard listening program worn by all participants at the same time. The participants must switch between the two programs during use to make the comparison.
Interventions
A mini behind-the-ear hearing aid that amplifies sounds and directs them into the ear. The music program within the hearing aid will provide amplification specifically tuned for listening to music.
A mini receiver-in-the-ear hearing aid that amplifies sounds and directs them into the ear. The standard listening program within the hearing aid will provide amplification specifically tuned for listening to speech and daily general sounds in the environment.
Eligibility Criteria
You may qualify if:
- All classifications of hearing loss (sensorineural, conductive, mixed)
- If the hearing loss is conductive or mixed it must be approved for amplification by a physician
- All shapes of hearing loss (flat, sloping, reverse slope, notch)
- Severity ranging from mild to severe
- German speaking
- Play a musical instrument
- Both genders
- Ages 18 and older
- Ability and willingness to sign the consent form
You may not qualify if:
- Normal hearing
- Contraindications for amplification
- Active ear disease
- Don't play an instrument
- Inability to follow the procedures of the study due to language problems, psychological disorders, dementia, or other cognitive problems of the participant
- A reduced mobility making them unable to attend weekly study appointments
- A reduced ability to describe auditory impressions and the usage of the hearing aids
- Uncooperative so that it is not possible to record a valid pure tone audiogram
- A strongly reduced dexterity
- Central hearing disorders
- Bernafon employees
- Family members of Bernafon employees
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bernafon AGlead
Study Sites (1)
Bernafon AG
Bern, 3018, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Simon, AuD
Bernafon AG
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The order of the programs is blinded so that subjects don't know which slot (2 or 3) contains the music program or the general program. Slot 1 always has a general program for everyday speech understanding.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2021
First Posted
June 25, 2021
Study Start
November 1, 2021
Primary Completion
December 6, 2021
Study Completion
December 6, 2021
Last Updated
July 26, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
The anonymized data that is shared in the report will be made available to other researchers.